Prothrombin San Antonio: A single amino acid substitution at a Factor Xa activation site (Arg320 to His) results in dysprothrombinemia

Blood

Volumn 95, Issue 2, 2000, Pages 711-714

  Sun, William Y ^a   Burkart, Melissa C ^a   Holahan, Joseph R ^b   Degen, Sandra J F ^b  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^b TEXAS ONCOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTIGEN; ARGININE; BLOOD CLOTTING FACTOR 10A; DNA; HISTIDINE; NUCLEOTIDE; PROTHROMBIN; THROMBIN;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; CONTROLLED STUDY; DYSPROTHROMBINEMIA; EXON; FEMALE; GENE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNODIFFUSION; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0034651024     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.2.711     Document Type: Article

References (19)

1. Davie EW, Fujikawa K, Kisiel W. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry. 1991 ;30:10,363-10,370.
2. Degen SJF, Sun WY. The biology of prothrombin. Crit Rev Eukaryot Gene Expr. 1998;8:203-224.
3. Degen SJF. Prothrombin. In: High KA, Roberts HR. eds. Molecular Basis of Thrombosis and Hemostasis. New York: Marcel Dekker;1995:75-99.
4. Sun WY, Witte D, Degen JL, et al. Prothrombin deficiency results in embryonic and neonatal lethality in mice. Proc Natl Acad Sei U S A. 199895:7597-7602.
5. Xue J, Wu, Westfield LA, et al. Incomplete embry-onic lethality and fatal neonatal hemorrhage caused by prothrombin deficiency In mice. Proc Natl Acad Sei USA. 1998:95:7603-7607.
6. Owen PA. A quantitative one-stage method for the assay of prothrombin. Scan J Clin Lab Invest. 1949;1:81-89.
7. Bell Gl, Karam JH, Rutter WJ. Polymorphic DMA region adjacent to the 5' end of the human insulin gene. Proc Natl Acad Sei U S A. 1981 ;78:57595763.
8. Degen SJ, McDowell SA, Sparks LM, Scharrer I. Prothrombin Frankfurt: a dysfunctional prothrombin characterized by substitution of Glu-466 by Ala.Thromb Haemost. 1995;73:203-209.
9. Liu Q, Sommer SS. The SSCP phenomenon: addition of HEPES buffer dramatically affects electophoretic mobility. Biotechniques. 1998:25:5056.
10. Degen SJF, Davie EW. Nucleotide sequence of the gene for human prothrombin. Biochemistry. 1937:26:6165-6177.
11. iMyata, T, Zheng Y-Z, Kalo A, Kalo H. A point mutation (Arg271-Cys) of a homozygote for dysfunctional prothrombin, prothrombin Obihiro, which has a region of high sequence variability. Br J Haematol. 1995:90:688-692.
12. Degen SJF, MacGillivrary RTA, Davie EW. Characterization of the complementary deoxynucleic acid and gene coding for human prothrombin. Biochemistry. 1983:22:2087-2097.
13. Iwahana H, Yoshimoto K, Itakura M. Highly polymorphic region of the human prothrombin (F2) gene.. Human Genet. 1992;89:123-124.
14. Briet MJ, Noyes CM, Roberts HR, Griffith MJ. Cleavage and activation of human prothrombin by Echis carinatus venom. Thromb Res. 1982;27: 591-600.
15. Rhee MJ, Morris S, Kosow DP. Role of meizothrombin and meizothrombin-(desF1) in the conversion of prothrombin to thrombin by Echis carinatus venom. Biochemistry. 1982;21:3437-3443.
16. Huisse M-G, Dreyfus M, Guillin M-C. Prothrombin Clamart: prothrombin variant with defective Arg 320-lle cleavage by factor Xa. Thromb Res. 1986; 44:11-21.
17. James HL, Kim DJ. Zheng D-Q, Girolami A. Prothrombin Padua I: incomplete activation due to anamino acid substitution at a factor Xa cleavage site. Blood Coagul Fibrinolysis. 1994:5:841-844.
18. O'Marcaigh AS, Nichols WL, Hassinger NL, et al. Genetic analysis and functional characterization of prothrombins Corpus Christi (Arg 382-Cys), Dhahran (Arg271-His), and Hypoprothrombinemia. Blood. 1996:88:2611-2618.
19. Rabiet M-J, Furie BC, Furie B. Molecular defect of prothrombin Barcelona: substitution of cysteine förarginine at residue 273. J Biol. Chem. 1986; 261:15,045-15,048.